Deep Medicine Acquisition... (DMAQ)
NASDAQ: DMAQ
· Real-Time Price · USD
2.96
-5.43 (-64.72%)
At close: Jan 31, 2024, 10:00 PM
Deep Medicine Acquisition Income Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Revenue | 37.36M | 31.97M | 10.11M | 3.87M | 90K | 90K | 90K | 90K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 12.19M | 10.47M | 3.24M | 1.33M | 45K | 60K | 60K | 60K | 60K | 60K | 60K | 60K | 91K | 76K | 61K |
Gross Profit | 25.17M | 21.5M | 6.87M | 2.54M | 45K | 30K | 30K | 30K | -60K | -60K | -60K | -60K | -91K | -76K | -61K |
Operating Income | -2.36M | -1.48M | -543.06K | -1.68M | -1.75M | -746.11K | -2.31M | -2.57M | -1.89M | -2.68M | -941.44K | -457.28K | -383.27K | -230.67K | -136.89K |
Interest Income | 145.52K | 90.93K | 165.9K | 127.31K | 90.69K | 90.69K | 552.16K | 552.16K | 552.16K | 552.16K | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -12.2M | -9.89M | -2.26M | -2.46M | -1.56M | -554.6K | -449.81K | -342.66K | 142.44K | -638.75K | -551.97K | -414.05K | -290.09K | -154.67K | -75.89K |
Net Income | -12.2M | -9.89M | -2.26M | -2.46M | -1.55M | -612.16K | 59.79K | 297.35K | 780.28K | 67.51K | -412.87K | -405.36K | -290.09K | -154.67K | -75.89K |
Selling & General & Admin | 11.97M | 9.61M | 4.29M | 3.04M | 1.57M | 1.6M | 2M | 1.94M | 1.56M | 1.3M | 663.25K | 409.91K | 292.27K | 154.67K | 75.89K |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 3.14M | 2.74M | 120.71K | 179.63K | 339.4K | 292.8K | 273.92K | 230K | 30K | 45K | 45K | 30K | 30K | 15K | n/a |
Operating Expenses | 15.11M | 12.35M | 4.4M | 3.19M | 1.88M | 1.87M | 2.24M | 2.14M | 1.56M | 1.3M | 663.25K | 409.91K | 292.27K | 154.67K | 75.89K |
Interest Expense | -10.22M | -8.72M | -1.79M | -820.91K | n/a | n/a | n/a | n/a | 12.63K | 12.63K | 12.63K | 12.63K | n/a | n/a | n/a |
Selling & Marketing Expenses | 4.62M | 4.62M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 27.3M | 22.82M | 7.64M | 4.51M | 1.91M | 1.91M | 2.27M | 2.17M | 1.58M | 1.3M | 663.25K | 409.91K | 292.27K | 154.67K | 75.89K |
Income Tax Expense | -110.53K | -110.53K | n/a | 110.53K | 99.69K | 168.1K | -399.06K | -640.01K | -637.85K | -706.26K | -139.1K | -8.69K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 11.63M | 11.63M | 13.38M | 13.28M | 4.36M | 4.39M | 4.61M | 2.31M | 15.39M | 16.43M | 16.43M | 8.74M | 12.35M | 16.43M | 16.43M |
Shares Outstanding (Diluted) | 11.63M | 11.63M | 13.38M | 13.28M | 4.36M | 4.39M | 4.61M | 10M | 15.39M | 16.43M | 16.43M | 8.74M | 12.35M | 16.43M | 16.43M |
EPS (Basic) | -684.06 | -684.05 | -4.76 | -0.32 | -0.48 | -0.36 | -0.27 | -0.22 | 0.04 | -0.01 | -0.04 | -0.04 | -0.02 | -0.01 | -0.00 |
EPS (Diluted) | -1.03 | -0.89 | -0.27 | -0.32 | -0.27 | -0.14 | -0.06 | -0.00 | 0.04 | -0.01 | -0.04 | -0.04 | -0.02 | -0.01 | -0.00 |
EBITDA | -15.74M | -14.51M | 87.24K | -1.27M | 1.61M | 132.26K | -585.47K | -102.83K | -2.36M | -888.44K | -170.72K | -187.22K | -75.89K | -75.89K | -75.89K |
EBIT | n/a | n/a | n/a | -261.56K | -1.12M | -475.76K | -1.75M | -1.87M | -1.2M | -1.84M | -570.97K | -217.22K | -136.89K | -136.89K | -136.89K |
Depreciation & Amortization | 351.34K | 311.76K | -130.27K | -351.34K | 1.07M | -1.01M | -351.48K | n/a | -1.42M | 723.44K | 171.28K | 55.87K | 93.18K | 128.75K | 113.75K |